6.18
Finanzdaten der 4 D Molecular Therapeutics Inc-Aktie (FDMT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
7.14%
0.015
|
0.014 | 0.001 | 0.003 | 0.005 |
Operating Expenses |
10.88%
59.47
|
53.63 | 56.12 | 51.13 | 42.46 |
Benefits Costs and Expenses |
100.00%
-
|
47.99 | 49.67 | - | - |
Costs And Expenses |
23.93%
59.47
|
47.99 | 49.67 | 51.13 | 42.46 |
Depreciation and Amortization |
10.94%
1.166
|
1.051 | 1.096 | 1.19 | 1.194 |
Operating Income/Loss |
10.88%
-59.46
|
-53.62 | -56.12 | -51.13 | -42.46 |
Nonoperating Income/Loss |
15.06%
4.798
|
5.649 | 6.446 | 7.289 | 7.503 |
Income/Loss From Continuing Operations Before Tax |
100.03%
0.015
|
-47.97 | -49.67 | 0.003 | -34.95 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
13.94%
-54.66
|
-47.97 | -49.67 | -43.84 | -34.95 |
|
13.94%
-54.66
|
-47.97 | -49.67 | -43.84 | -34.95 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.33%
55.93
|
55.74 | 0.566 | 55.55 | 55.28 |
Diluted Average Shares |
0.33%
55.93
|
55.74 | 0.566 | 55.55 | 55.28 |
Basic Earnings Per Share |
13.95%
-0.98
|
-0.86 | -0.90 | -0.79 | -0.63 |
Diluted Earnings Per Share |
13.95%
-0.98
|
-0.86 | -0.90 | -0.79 | -0.63 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):